Risperidone

Overview

Risperidone is an atypical antipsychotic used to treat schizophrenia, bipolar disorder, and irritability associated with autistic disorder. It works by antagonizing dopamine D2 receptors and serotonin type 2A (5-HT2A) receptors in the brain.

API suppliers (24)

Suppliers of Risperidone evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• Cipla USA, Inc.USA1 active DMF
• Zydus Lifesciences LimitedIndia1 active DMF GMP on record
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
• INTERQUIM SAPeru1 active DMF GMP on record
• Ipca Laboratories LimitedIndia1 active DMF GMP on record
• Zhejiang Huahai Pharmaceutical Co., Ltd.China1 active DMF GMP on record
• WUXI JIDA PHARMACEUTICAL CO LTD1 active DMF
• CHIERON ACTIVE INGREDIENTS PRIVATE LTDIndia1 active DMF
• ICROM SRLItaly1 active DMF GMP on record
• STHREE CHEMICALS PRIVATE LTD1 active DMF
• TAPI NL BVNetherlands1 active DMF
• INKE SASpain1 active DMF
• MATRIX PHARMACORP PRIVATE LTDIndia1 active DMF
• Sun Pharmaceutical Industries LimitedIndia1 active DMF GMP on record
• Torrent PharmaceuticalsIndia1 active DMF GMP on record
• Gedeon Richter Usa
• Lupin LimitedIndia GMP on record
• WANBURY LTDIndia
• JIANGSU JIWA RINTECH PHARMACEUTICAL CO LTD
• MEDICHEM SASpain GMP on record
• DR REDDYS LABORATORIES LTD GMP on record
• Rpg Life Sciences Ltd.India GMP on record
• Apotex Pharmachem India Pvt. Ltd.India
• ICROM SPA GMP on record

Patent & exclusivity (US)

Per the FDA Orange Book (142 approved US products), the latest listed US patent on Risperidone expires 17 Mar 2042 and exclusivity 12 May 2026. Generic API sourcing typically opens up once these lapse.

Therapeutic areas